• State of Digital Clinical Trials Podcast

  • By: Richard Young
  • Podcast

State of Digital Clinical Trials Podcast

By: Richard Young
  • Summary

  • State of Digital Clinical Trials is a Veeva podcast hosted by Richard Young, Vice President of Strategy for Vault Clinical Data Management Suite at Veeva. Over the next few months, Richard will be speaking to a series of expert guests from across pharma, biotech, and CROs to discuss their experiences, challenges, and ideas for the future of digital clinical trials. Will new technology make clinical trials more patient- and site-centric?
    Richard Young
    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • The Launch of Boehringer Ingelheim's One Medicine Program
    Oct 4 2024

    Nicole Raleigh hosts this special episode on-site from Boehringer Ingelheim’s Human Pharmacology Center in Biberach, Germany. Andrea Kloeble and Daniel Schwenk are part of the team reimagining drug development at Boehringer Ingelheim through the One Medicine Platform.

    They explain how their organization strives for medical excellence, and why exponential growth in study data volumes and sources requires a connected technology ecosystem. And Richard is in the guest seat this week to put this transformative initiative into industry context: as he explains, life sciences is no longer willing to accept single-use data.


    Show more Show less
    26 mins
  • Against All Odds: Finding a Treatment for SPG50
    Sep 25 2024

    We can think of no better way to kick off Season 3. In a deeply personal and moving episode, two patient advocates share their stories of working tirelessly to deliver a safe and effective gene therapy for children suffering from spastic paraplegia 50 (SPG50).


    After his infant son received a diagnosis of this ultrarare neurodegenerative disease in 2017, Terry Pirovolakis began a daunting four-year journey to find a breakthrough treatment that would help Michael and other affected children. We also hear from Samuela Bellini, who wants to bring this therapy to children in Italy. Their achievements, and reflections, are an inspiration for our industry.


    Subscribe to State of Digital Clinical Trials, a Veeva podcast, to get new episodes as soon as they are released.


    Show more Show less
    29 mins
  • Are We Too Risk Averse in Clinical Research?
    May 29 2024

    This week, Richard Young speaks to Ken Getz, executive director and research professor at Tufts Center for the Study of Drug Development.


    Already well-known in our industry for his pioneering research on protocol design complexity and trial efficiency, Ken’s most recent study found that the average number of amendments per protocol increased by almost 60% over the past seven years.


    In this episode, Richard and Ken debate whether clinical research is striking the right balance in its approach to risk and innovation, the problem-solving role played by sites, and CISCRP’s work to improve public trust in scientific advances.


    Subscribe to State of Digital Clinical Trials, a Veeva podcast, to get new episodes as soon as they are released.

    Show more Show less
    45 mins

What listeners say about State of Digital Clinical Trials Podcast

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.